-
Bharti Airtel
1,905.00 1,745.00(%) -
ICICI Bank
1,412.30 1,187.55(%) -
HDFC Bank
726.50 726.75(%) -
C P C L
1,449.00 1,354.00(%) -
Gland Pharma
2,989.25 2,679.00(%) -
Life Insurance
410.00 468.30(%) -
Narayana Hrudaya
1,860.45 2,094.30(%) -
Cupid
277.00 267.90(%) -
Lumax Auto Tech.
2,088.95 1,898.65(%) -
Info Edg.(India)
1,391.60 1,439.95(%) -
Multi Comm. Exc.
2,886.00 3,479.80(%) -
ERIS Lifescience
1,380.00 1,237.90(%) -
One 97
1,638.80 1,594.80(%) -
Endurance Tech.
3,020.00 3,078.95(%) -
Aarti Pharma
932.50 946.45(%) -
Eternal
318.30 368.40(%) -
Finolex Cables
1,225.00 1,204.15(%) -
M & M
3,455.65 2,896.30(%) -
Hitachi Energy
34,729.35 16,104.00(%) -
Zydus Lifesci.
1,205.00 1,181.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Manipal Health Enterprises Ltd Healthcare
- Indian Private
- BSE Code : 73020.0
- ISIN : INE459N01021
-
Today’s Low
666.00 -
Today’s High
693.40
-
Open
676.00 -
Perv Close
677.95 -
52W Low
625.45 -
52W High
693.40
Key Indicators
-
P/E(TTM)
168.67
-
Mar.Cap (₹Cr.)
90,280.91
-
Div & Yield %
0.00
-
Book Value(₹)
100.51
-
Debt-Equity Ratio
1.24
-
AGM Date
10-Aug-2026
-
EPS
4.07
-
P/E Ratio
168.67
Financials Ratios
-
Debt-Equity Ratio
1.01
-
Mar.Cap (₹Cr.)
90,280.91
-
RONW (%)
18.09
-
ROCE (%)
17.60
Score Board
-
Equity (₹ in Cr.)
263.08
-
BV (₹)
100.50
-
Sales( ₹ in Cr.)
3,162.65
-
NP (in Cr.)
535.30
-
NP Var(%)
41.0
-
Div%
0.0
-
CPS (₹)
5.20
-
EPS (₹)
4.10
-
Traded Value (₹ in Lakhs)
90,300.64
-
52 Week High
693.40
-
52 Week Low
625.45
-
Price BSE
687.0
-
Price NSE
686.00
-
Market Capital( in Cr.)
90,300.64
-
P/C Ratio
132.10
-
P/E Ratio
168.80
-
Price Vs.BV
4.10
-
05-Aug-2026( 02:19)
Corporate News - Manip... - Manipal Health Enterprises Lim...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 3,162.65 | 2,753.60 | 2,408.19 | 2,119.56 | 1,406.76 | 1,672.18 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 3,162.65 | 2,753.60 | 2,408.19 | 2,119.56 | 1,406.76 | 1,672.18 |
| Other Income | 100.66 | 80.82 | 65.11 | 175.58 | 72.38 | 50.93 |
| Stock Adjustments | -3.30 | 14.89 | -21.39 | 23.61 | -13.31 | 1.06 |
| Total Income | 3,260.01 | 2,849.31 | 2,451.91 | 2,318.75 | 1,465.83 | 1,724.17 |
| EXPENDITURE : | ||||||
| Raw Materials | 604.46 | 546.75 | 478.51 | 587.35 | 305.22 | 358.82 |
| Power and Fuel Cost | 32.09 | 31.53 | 30.21 | 28.33 | 26.95 | 29.60 |
| Employee Cost | 493.16 | 415.59 | 351.14 | 305.54 | 239.95 | 254.03 |
| Other Manufacturing Expenses | 821.72 | 692.00 | 572.90 | 454.28 | 45.61 | 51.06 |
| Selling and Administration Expenses | 326.85 | 272.29 | 238.18 | 211.86 | 390.21 | 413.59 |
| Miscellaneous Expenses | 35.07 | 78.72 | 185.10 | 79.43 | 174.92 | 200.36 |
| Employee Benefit Expenses | 493.16 | 415.59 | 351.14 | 305.54 | 239.95 | 254.03 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | -5.09 | 0.00 | 0.00 |
| Total Expenses | 2,313.35 | 2,036.88 | 1,856.04 | 1,671.88 | 1,182.86 | 1,307.46 |
| Operating Profit | 946.66 | 812.43 | 595.87 | 646.87 | 282.97 | 416.71 |
| Interest | 149.02 | 168.41 | 171.65 | 185.40 | 150.82 | 157.29 |
| Gross Profit | 797.64 | 644.02 | 424.22 | 461.47 | 132.15 | 259.42 |
| Depreciation | 148.99 | 139.13 | 139.35 | 125.45 | 128.16 | 122.76 |
| Profit Before Tax | 648.65 | 504.89 | 284.87 | 336.02 | 3.99 | 136.66 |
| Current Tax | 155.47 | 138.87 | 99.78 | 80.83 | 11.48 | 20.14 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -42.12 | 29.66 | -9.25 | -8.53 | 8.90 | 22.22 |
| Reported Net Profit | 535.30 | 336.36 | 194.34 | 263.72 | -16.39 | 94.30 |
| Extraordinary Items | 0.00 | -42.10 | -73.25 | 101.83 | 361.65 | -24.39 |
| Adjusted Net Profit | 535.30 | 378.46 | 267.59 | 161.89 | -378.04 | 118.69 |
| Adjustment below Net Profit | -2.51 | -34.80 | 1.11 | -0.85 | 0.14 | 0.00 |
| P & L Balance brought forward | 1,153.77 | 852.21 | 545.24 | 282.37 | 298.62 | 204.41 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 1,686.56 | 1,153.77 | 740.69 | 545.24 | 282.37 | 298.71 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 69.47 | 44.47 | 25.70 | 34.87 | -2.39 | 13.73 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - | - |
| Book Value | 676.69 | 515.38 | 446.28 | 419.84 | 257.63 | 263.48 |
| Book Value(Adj)-Unit Curr | - | - | - | - | - | - |
